{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05250973",
            "orgStudyIdInfo": {
                "id": "CR109160"
            },
            "secondaryIdInfos": [
                {
                    "id": "2021-002639-48",
                    "type": "EUDRACT_NUMBER"
                },
                {
                    "id": "54767414AMY2009",
                    "type": "OTHER",
                    "domain": "Janssen Research & Development, LLC"
                },
                {
                    "id": "2023-507069-25-00",
                    "type": "REGISTRY",
                    "domain": "EUCT number"
                }
            ],
            "organization": {
                "fullName": "Janssen Research & Development, LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis",
            "officialTitle": "A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis",
            "acronym": "AQUARIUS",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-daratumumab-based-therapies-in-participants-with-amyloid-light-chain-al-amyloidosis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": true
            },
            "startDateStruct": {
                "date": "2022-03-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-29",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-02-11",
            "studyFirstSubmitQcDate": "2022-02-11",
            "studyFirstPostDateStruct": {
                "date": "2022-02-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Janssen Research & Development, LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to characterize cardiac safety of Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone (D-VCd) treatment regimens (Arm A: daratumumab + immediate VCd treatment and Arm B: daratumumab + deferred VCd) in newly diagnosed systemic amyloid light chain (AL) amyloidosis with cardiac involvement and to identify potential mitigation strategies for cardiac toxicity (cohort 1); to characterize the pharmacokinetics of subcutaneous (SC) daratumumab, among racial and ethnic minorities, including Black or African American, with newly diagnosed AL amyloidosis treated with D-VCd (cohort 2)."
        },
        "conditionsModule": {
            "conditions": [
                "Amyloidosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Participants of Cohort 1 will be randomized to either Arm A or Arm B of Cohort 1 in a 2:1 ratio. For Cohort 2, participants will be enrolled without randomization.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort1 (Arm A): Daratumumab + Immediate Cyclophosphamide, Bortezomib and Dexamethasone (VCd)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with newly diagnosed systemic amyloid light chain (AL) amyloidosis with Mayo Cardiac Stage II and IIIa cardiac involvement will receive daratumumab 1800 milligrams (mg) subcutaneously (SC) starting on Day 1 once weekly (q1w) up to Day 22 for cycles 1-2, on Days 1 and 15 for cycles 3-6, and on Day 1 for cycles 7-24 of a 28-day cycle. Participants will also receive VCd (cyclophosphamide 300 milligrams per meter square \\[mg/m\\^2\\] either orally or intravenously \\[IV\\], bortezomib 1.3 mg/m\\^2 SC or IV, dexamethasone 40 mg weekly either orally or IV) weekly starting at Cycle 1 Day 1 up to Day 22 in every 28-day cycle for a maximum of 6 cycles (Cycle 6 Day 22).",
                    "interventionNames": [
                        "Drug: Daratumumab",
                        "Drug: Cyclophosphamide",
                        "Drug: Bortezomib",
                        "Drug: Dexamethasone"
                    ]
                },
                {
                    "label": "Cohort1 (Arm B): Daratumumab + Deferred VCd",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with newly diagnosed systemic AL amyloidosis with Mayo Cardiac Stage II and IIIa cardiac involvement will receive SC daratumumab 1800mg on Day 1 once weekly (q1w) up to Day 22 for cycles 1-2, on Days 1 and 15 for cycles 3-6, and on Day 1 for cycles 7-24 of a 28-day cycle. Participants will also receive VCd (Cyclophosphamide 300 mg/m\\^2 either orally or IV, Bortezomib 1.3 mg/m\\^2 SC or IV, Dexamethasone 40 mg weekly either orally or IV) starting at Cycle 4 Day 1, weekly (Days 1, 8, 15, 22) in every 28-day cycle for a maximum of 6 cycles (Cycle 9 Day 22).",
                    "interventionNames": [
                        "Drug: Daratumumab",
                        "Drug: Cyclophosphamide",
                        "Drug: Bortezomib",
                        "Drug: Dexamethasone"
                    ]
                },
                {
                    "label": "Cohort 2: Daratumumab + VCd",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with racial and ethnic minorities, including Black or African American participants, with newly diagnosed AL amyloidosis will receive SC injection of daratumumab 1800 mg SC on Day 1 once weekly (q1w) up to Day 22 for cycles 1-2, on Days 1 and 15 for cycles 3-6, and on Day 1 for cycles 7-24 of a 28-day cycle. Participants will also receive VCd (cyclophosphamide 300 milligrams per meter square \\[mg/m\\^2\\] either orally or intravenously \\[IV\\], bortezomib 1.3 mg/m\\^2 SC or IV, dexamethasone 40 mg weekly either orally or IV) weekly starting at Cycle 1 Day 1 up to Day 22 in every 28-day cycle for a maximum of 6 cycles (Cycle 6 Day 22).",
                    "interventionNames": [
                        "Drug: Daratumumab",
                        "Drug: Cyclophosphamide",
                        "Drug: Bortezomib",
                        "Drug: Dexamethasone"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Daratumumab",
                    "description": "Daratumumab will be administered subcutaneously.",
                    "armGroupLabels": [
                        "Cohort 2: Daratumumab + VCd",
                        "Cohort1 (Arm A): Daratumumab + Immediate Cyclophosphamide, Bortezomib and Dexamethasone (VCd)",
                        "Cohort1 (Arm B): Daratumumab + Deferred VCd"
                    ],
                    "otherNames": [
                        "JNJ-54767414"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cyclophosphamide",
                    "description": "Cyclophosphamide will be administered either orally or IV.",
                    "armGroupLabels": [
                        "Cohort 2: Daratumumab + VCd",
                        "Cohort1 (Arm A): Daratumumab + Immediate Cyclophosphamide, Bortezomib and Dexamethasone (VCd)",
                        "Cohort1 (Arm B): Daratumumab + Deferred VCd"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bortezomib",
                    "description": "Bortezomib will be administered by SC injection or IV.",
                    "armGroupLabels": [
                        "Cohort 2: Daratumumab + VCd",
                        "Cohort1 (Arm A): Daratumumab + Immediate Cyclophosphamide, Bortezomib and Dexamethasone (VCd)",
                        "Cohort1 (Arm B): Daratumumab + Deferred VCd"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Dexamethasone",
                    "description": "Dexamethasone will be administered orally or IV.",
                    "armGroupLabels": [
                        "Cohort 2: Daratumumab + VCd",
                        "Cohort1 (Arm A): Daratumumab + Immediate Cyclophosphamide, Bortezomib and Dexamethasone (VCd)",
                        "Cohort1 (Arm B): Daratumumab + Deferred VCd"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants with Cardiac Events of Any Toxicity Grade",
                    "description": "Number of participants with cardiac events of any toxicity grade will be reported.",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Observed Concentration Immediately Prior to the Next Study Treatment Administration (Ctrough) of Daratumumab",
                    "description": "Ctrough is defined as the observed concentration immediately prior to the next study treatment administration.",
                    "timeFrame": "Cycle 3 Day 1 predose (each cycle is of 28 days)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Overall Complete Hematologic Response (HemCR) Rate",
                    "description": "Overall HemCR rate is defined as percentage of participants who achieve HemCR during or after the study treatment.",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "HemCR Rate",
                    "description": "HemCR rate at 6 month is defined as percentage of participants who achieve HemCR at 6 month during or after the study treatment.",
                    "timeFrame": "At 6 months"
                },
                {
                    "measure": "Very Good Partial Response (VGPR) or Better Rate",
                    "description": "Hematologic greater than or equal to (\\>=) VGPR rate is defined as percentage of participants who achieve hematologic response of VGPR or better.",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "Time to HemCR or (VGPR or Better)",
                    "description": "For participants who achieve HemCR (or \\>=VGPR), time to HemCR (or \\>=VGPR) is defined as the time between the date of first study treatment and the first efficacy evaluation at which the participant has met all criteria for hematologic complete response (CR) (or \\>=VGPR).",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "Duration of Response (HemCR and VGPR or Better)",
                    "description": "For participants who achieve HemCR (or \\>=VGPR), duration of HemCR (or \\>=VGPR) is defined as the time between the date of initial documentation of HemCR (or \\>=VGPR) to the date of first documented evidence of hematologic progressive disease or death, whichever comes first.",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "Organ Response Rate (OrRR)",
                    "description": "Organ response rate is defined as the percentage of participants who achieve organ response in each corresponding organ (kidney, heart, liver).",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "OS is measured from the date of first study treatment to the date of the participant's death.",
                    "timeFrame": "Until Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "Time to Subsequent Therapy",
                    "description": "Time to subsequent therapy for amyloid light chain (AL) amyloidosis is defined as the time from the date of first study treatment to the start date of subsequent AL amyloidosis (non-protocol) treatment.",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "Number of Participants with Adverse Events (AEs) by Severity",
                    "description": "Number of participants with AEs by severity will be reported. An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/ biological agent under study.",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "Serum Concentration of Daratumumab",
                    "description": "Serum samples will be analyzed to determine concentrations of daratumumab.",
                    "timeFrame": "Up to 3 years"
                },
                {
                    "measure": "Number of Participants with Antibodies to Daratumumab",
                    "description": "Number of participants with antibodies to daratumumab will be reported.",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "Number of Participants with Antibodies to Recombinant Human Hyaluronidase PH20 Enzyme (rHuPH20)",
                    "description": "Number of participants with antibodies to rHuPH20 will be reported.",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                },
                {
                    "measure": "Change from Baseline in Clinical Signs and Symptoms Score of Cardiac AL Amyloidosis",
                    "description": "Change from baseline in clinical signs and symptoms score of cardiac AL amyloidosis will be reported.",
                    "timeFrame": "Up to Cycle 12 or Month 12 (whichever occurs later)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Cohort 1: Cardiac involvement (amyloid light chain \\[AL\\] amyloidosis Mayo Cardiac Stage II and Stage IIIa) with or without other organ(s) involved; Cohort 2: One or more organs impacted by systemic AL amyloidosis according to consensus guidelines\n* Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0, 1 or 2\n* A female participant of childbearing potential must have a negative serum or urine test at screening and within 72 hours of the first dose of study treatment and must agree to further serum or urine pregnancy tests during the study\n* A male participant must agree not to donate sperm for the purpose of reproduction during the study and for a minimum of 6 months after receiving the last dose of cyclophosphamide or 100 days after discontinuation of daratumumab, whichever is longer\n* Cohort 2 only: self-identified racial and ethnic minorities, including Black or African American\n* Measurable disease at screening defined by one of the following:\n\nDifference between iFLC and uninvolved FLC (dFLC) \\>= 40mg/L per central laboratory Serum involved free light chain (iFLC) \\>= 40 mg/L with an abnormal kappa:lambda ratio Serum M-protein \\>= 0.5 g/dL\n\nExclusion Criteria:\n\n* Prior therapy for systemic AL amyloidosis or multiple myeloma including medications that target cluster of differentiation 38 (CD38), with the exception of 160 milligrams(mg) dexamethasone or equivalent corticosteroid maximum exposure prior to randomization/enrollment\n* Previous or current diagnosis of symptomatic multiple myeloma, including the presence of lytic bone disease, plasmacytomas, \\>=60% plasma cells in the bone marrow, or hypercalcemia related to myeloma.\n* Participant received any of the following therapies:\n\n  1. treatment with an investigational drug or used an invasive investigational medical device within 14 days or at least 5 half-lives, whichever is less;\n  2. vaccinated with an investigational vaccine (except for COVID-19) live, attenuated or replicating viral vector vaccines less than (\\<) 4 weeks prior to randomization/enrollment. Participants who are taking strong Cytochrome P450 3A4(CYP3A4) inducers must discontinue their use at least 5 half-lives prior to the first dose of bortezomib\n* Stem cell transplantation -Planned stem cell transplant during the first 9 cycles of protocol therapy are excluded. Stem cell collection during the first 9 cycles of protocol therapy is permitted\n* Grade 2 sensory or Grade 1 painful peripheral neuropathy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Study Contact",
                    "role": "CONTACT",
                    "phone": "844-434-4210",
                    "email": "Participate-In-This-Study@its.jnj.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Janssen Research & Development, LLC Clinical Trial",
                    "affiliation": "Janssen Research & Development, LLC",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Smilow Cancer Hospital/Yale Cancer Center",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06510",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Moffitt Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Winship Cancer Institute Emory University",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Tufts Medical Center",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02111",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Boston University Medical Center",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02118",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Barbara Ann Karmanos Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48201",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Levine Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Charlotte",
                    "state": "North Carolina",
                    "zip": "28204",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.22709,
                        "lon": -80.84313
                    }
                },
                {
                    "facility": "University Hospital of Cleveland",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Ohio Health Research Institute",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43214",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "West Penn Hospital",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15224",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "UT Southwestern Medical Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "VCU Medical Center",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23219",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                },
                {
                    "facility": "University of Washington",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "90805",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Tom Baker Cancer Center",
                    "status": "RECRUITING",
                    "city": "Calgary",
                    "state": "Alberta",
                    "zip": "T2N 4N2",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 51.05011,
                        "lon": -114.08529
                    }
                },
                {
                    "facility": "Cross Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 1Z2",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "University Health Network UHN Princess Margaret Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 2M9",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Peking University First Hospital",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "zip": "100034",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Peking University People s Hospital",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "zip": "100044",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "West China Hospital Si Chuan University",
                    "status": "RECRUITING",
                    "city": "Chengdu",
                    "zip": "610041",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.66667,
                        "lon": 104.06667
                    }
                },
                {
                    "facility": "First affiliated Hospital of Zhejiang University",
                    "status": "RECRUITING",
                    "city": "Hangzhou",
                    "zip": "310020",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.29365,
                        "lon": 120.16142
                    }
                },
                {
                    "facility": "Ruijin Hospital Shanghai Jiao Tong University",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "zip": "200025",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "CHU de Limoges",
                    "status": "COMPLETED",
                    "city": "Limoges Cedex",
                    "zip": "87042",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.83153,
                        "lon": 1.25781
                    }
                },
                {
                    "facility": "Centre hospitalier Lyon-Sud",
                    "status": "RECRUITING",
                    "city": "Pierre Benite cedex",
                    "zip": "69495",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.7009,
                        "lon": 4.82511
                    }
                },
                {
                    "facility": "CHU De Poitiers",
                    "status": "RECRUITING",
                    "city": "Poitiers",
                    "zip": "86000",
                    "country": "France",
                    "geoPoint": {
                        "lat": 46.58333,
                        "lon": 0.33333
                    }
                },
                {
                    "facility": "CHU Rangueil",
                    "status": "RECRUITING",
                    "city": "Toulouse",
                    "zip": "31400",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.60426,
                        "lon": 1.44367
                    }
                },
                {
                    "facility": "Charite Campus Benjamin Franklin",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "zip": "12203",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "Universitatsklinikum Essen",
                    "status": "COMPLETED",
                    "city": "Essen",
                    "zip": "45122",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.45657,
                        "lon": 7.01228
                    }
                },
                {
                    "facility": "Universitaetsklinikum Heidelberg Medizinische Klinik V",
                    "status": "RECRUITING",
                    "city": "Heidelberg",
                    "zip": "69120",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.40768,
                        "lon": 8.69079
                    }
                },
                {
                    "facility": "Alexandra General Hospital of Athens",
                    "status": "RECRUITING",
                    "city": "Athens",
                    "zip": "11528",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 37.97945,
                        "lon": 23.71622
                    }
                },
                {
                    "facility": "Universit\u00e0 Degli Studi Di Napoli Federico Ii",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "zip": "80131",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Fondazione IRCCS Policlinico San Matteo",
                    "status": "RECRUITING",
                    "city": "Pavia",
                    "zip": "27100",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.19205,
                        "lon": 9.15917
                    }
                },
                {
                    "facility": "DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA - UNIVERSIT\u00e0 ''LA SAPIENZA''",
                    "status": "COMPLETED",
                    "city": "Roma",
                    "zip": "00161",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "University Medical Center Groningen",
                    "status": "RECRUITING",
                    "city": "Groningen",
                    "zip": "9713 GZ",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 53.21917,
                        "lon": 6.56667
                    }
                },
                {
                    "facility": "Hospital Maastricht University Medical Center",
                    "status": "COMPLETED",
                    "city": "Maastricht",
                    "zip": "6229 HX",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 50.84833,
                        "lon": 5.68889
                    }
                },
                {
                    "facility": "UMC Utrecht",
                    "status": "RECRUITING",
                    "city": "Utrecht",
                    "zip": "3584 CX",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.09083,
                        "lon": 5.12222
                    }
                },
                {
                    "facility": "Hosp. Univ. Germans Trias I Pujol",
                    "status": "RECRUITING",
                    "city": "Badalona",
                    "zip": "08916",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.45004,
                        "lon": 2.24741
                    }
                },
                {
                    "facility": "Hosp Univ Vall D Hebron",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hosp Clinic de Barcelona",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08036",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Clinica Univ. de Navarra",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28027",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Clinica Univ. de Navarra",
                    "status": "RECRUITING",
                    "city": "Pamplona",
                    "zip": "31008",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 42.81687,
                        "lon": -1.64323
                    }
                },
                {
                    "facility": "Hosp Clinico Univ de Salamanca",
                    "status": "RECRUITING",
                    "city": "Salamanca",
                    "zip": "37007",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.96882,
                        "lon": -5.66388
                    }
                },
                {
                    "facility": "Leicester Royal Infirmary - Haematology",
                    "status": "RECRUITING",
                    "city": "Leicester",
                    "zip": "LE1 5WW",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.6386,
                        "lon": -1.13169
                    }
                },
                {
                    "facility": "University College Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "NW1 2PG",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The data sharing policy of the Janssen Pharmaceutical Companies of Johnson \\& Johnson is available at www.janssen.com/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu",
            "url": "https://www.janssen.com/clinical-trials/transparency"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000686",
                    "term": "Amyloidosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000057165",
                    "term": "Proteostasis Deficiencies"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4021",
                    "name": "Amyloidosis",
                    "asFound": "Amyloidosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28747",
                    "name": "Proteostasis Deficiencies",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003907",
                    "term": "Dexamethasone"
                },
                {
                    "id": "D000003520",
                    "term": "Cyclophosphamide"
                },
                {
                    "id": "D000069286",
                    "term": "Bortezomib"
                },
                {
                    "id": "C000556306",
                    "term": "Daratumumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000000932",
                    "term": "Antiemetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "asFound": "Effect of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7102",
                    "name": "Dexamethasone",
                    "asFound": "High",
                    "relevance": "HIGH"
                },
                {
                    "id": "M235549",
                    "name": "Dexamethasone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M376",
                    "name": "Bortezomib",
                    "asFound": "Includes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M272211",
                    "name": "Daratumumab",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}